Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 1 of 1 entries
Sorted by: Best Match Show Resources per page
Biological and genetic evaluation of IL-23/IL-17 pathway in ankylosing spondylitis patients.

Central-European journal of immunology

Deveci H, Turk AC, Ozmen ZC, Demir AK, Say Coskun SU.
PMID: 32140056
Cent Eur J Immunol. 2019;44(4):433-439. doi: 10.5114/ceji.2019.92805. Epub 2020 Jan 20.

Ankylosing spondylitis is the most common form of the chronic inflammatory disease group known as spondyloarthritides. Recent discoveries of the CD4+ Th17 cells and IL-23/IL-17 axis have changed the paradigms in many autoimmune diseases. In this study, we aimed...

Cite
Deveci H, Turk AC, Ozmen ZC, et al. Biological and genetic evaluation of IL-23/IL-17 pathway in ankylosing spondylitis patients. Cent Eur J Immunol. 2020;44(4):433-439doi: 10.5114/ceji.2019.92805.
Deveci, H., Turk, A. C., Ozmen, Z. C., Demir, A. K., & Say Coskun, S. U. (2019). Biological and genetic evaluation of IL-23/IL-17 pathway in ankylosing spondylitis patients. Central-European journal of immunology, 44(4), 433-439. https://doi.org/10.5114/ceji.2019.92805
Deveci, Hulya, et al. "Biological and genetic evaluation of IL-23/IL-17 pathway in ankylosing spondylitis patients." Central-European journal of immunology vol. 44,4 (2019): 433-439. doi: https://doi.org/10.5114/ceji.2019.92805
Deveci H, Turk AC, Ozmen ZC, Demir AK, Say Coskun SU. Biological and genetic evaluation of IL-23/IL-17 pathway in ankylosing spondylitis patients. Cent Eur J Immunol. 2019;44(4):433-439. doi: 10.5114/ceji.2019.92805. Epub 2020 Jan 20. PMID: 32140056; PMCID: PMC7050057.
Copy Download .nbib Format: NLM
Showing 1 to 1 of 1 entries